Visual impairment in myopic patients with breast cancer receiving adjuvant therapy with aromatase inhibitors

Clinical Breast Cancer

Volumn 9, Issue 3, 2009, Pages 184-186

  Epstein, Richard J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anastrozole; Exemestane; Letrozole; Macular hole; Retinal detachment

Indexed keywords

ANASTROZOLE; ANDROGEN; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; CYTOCHROME P450; ESTROGEN; EXEMESTANE; FLUOROURACIL; LETROZOLE; METHOTREXATE; ROSUVASTATIN; ANDROSTANE DERIVATIVE; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL EVALUATION; COLON POLYP; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESTROGEN SYNTHESIS; EYE EXAMINATION; FEMALE; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; MULTIMODALITY CANCER THERAPY; MUSCULOSKELETAL DISEASE; MYOPIA; NEUROPROTECTION; OPHTHALMOSCOPY; POLYPECTOMY; PRESCRIPTION; RETINA DETACHMENT; TREATMENT DURATION; TREATMENT REFUSAL; VISUAL ACUITY; VISUAL IMPAIRMENT; ASIAN; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; VISUAL DISORDER;

ADJUVANTS, PHARMACEUTIC; ANDROSTADIENES; AROMATASE INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MYOPIA; VISION, LOW; VISUAL ACUITY;

EID: 70350761930     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2009.n.030     Document Type: Article

References (33)

1. Naftolin F, Malaspina D. Estrogen, estrogen treatment and the post-reproductive woman's brain. Maturitas 2007;57:23-6.
2. Woolley CS. Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol 2007;47:657-80.
3. Roselli C F. Brain aromatase: roles in reproduction and neuroprotection. J Steroid Biochem Mol Biol 2007;106:143-50.
4. Zhao L, Brinton RD. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci 2006;7:24.
5. Lang Y, Lang N, Ben-Ami M, et al. [The effects of hormone replacement therapy (HRT) on the human eye]. Harefuah 2002;141:287-91, 313, 12.
6. Boekhoorn SS, Vingerling JR, Uitterlinden AG, et al. Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. Invest Ophthalmol Vis Sci 2007;48:1012-7.
7. Bourla DH, Sarraf D, Schwartz SD. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy. Am J Ophthalmol 2007;144:126-8.
8. Cronin BG, Lekich CK, Bourke RD. Tamoxifen therapy conveys increased risk of developing a macular hole. Int Ophthalmol 2005;26:101-5.
9. Toimela T, Tahti H, Salminen L. Retinal pigment epithelium cell culture as a model for evaluation of the toxicity of tamoxifen and chloroquine. Ophthalmic Res 1995;27(suppl 1):150-3.
10. Chuo JY, Lee TY, Hollands H, et al. Risk factors for posterior vitreous detachment: a case-control study. Am J Ophthalmol 2006;142:931-7.
11. Cascio C, Russo D, Drago G, et al. 17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res 2007;85:166-72.
12. Munaut C, Lambert V, Noel A, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol 2001;85:877-82.
13. Bucolo C, Drago F, Lin LR, et al. Neuroactive steroids protect retinal pigment epithelium against oxidative stress. Neuroreport 2005;16:1203-7.
14. Yu X, Tang Y, Li F, et al. Protection against hydrogen peroxide-induced cell death in cultured human retinal pigment epithelial cells by 17beta-estradiol: a differential gene expression profile. Mech Ageing Dev 2005;126:1135-45.
15. Li C, Tang Y, Li F, et al. 17beta-estradiol (betaE2) protects human retinal Muller cell against oxidative stress in vitro: evaluation of its effects on gene expression by cDNA microarray. Glia 2006;53:392-400.
16. Paimela T, Ryhanen T, Mannermaa E, et al. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. Immunol Lett 2007;110:139-44.
17. Rakic JM, Lambert V, Deprez M, et al. Estrogens reduce the expression of YKL-40 in the retina: implications for eye and joint diseases. Invest Ophthalmol Vis Sci 2003;44:1740-6.
18. Nakamura J, Savinov A, Lu Q, et al. Estrogen regulates vascular endothelial growth/permeability factor expression in 7, 12-dimethylbenz (a) anthraceneinduced rat mammary tumors. Endocrinology 1996;137:5589-96.
19. Bottini A, Generali D, Brizzi M P, et al. Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients. J Clin Oncol 2006;24:3623-8.
20. Suzuma I, Mandai M, Takagi H, et al. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 1999;40:2122-9.
21. Weinberger AW, Thiel M, Mohammadi B, et al. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment. Am J Ophthalmol 2007;144:294-6.
22. Nakamura J, Lu Q, Aberdeen G, et al. The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland. J Clin Endocrinol Metab 1999;84:1432-7.
23. Bender CM, Sereika SM, Brufsky AM, et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 2007;14:995-8.
24. Callard G V, Drygas M, Gelinas D. Molecular and cellular physiology of aromatase in the brain and retina. J Steroid Biochem Mol Biol 1993;44:541-7.
25. Salyer DL, Lund TD, Fleming DE, et al. Sexual dimorphism and aromatase in the rat retina. Brain Res Dev Brain Res 2001;126:131-6.
26. Eisner A, Falardeau J, Toomey MD, et al. Retinal hemorrhages in anastrozole users. Optom Vis Sci 2008;85:301-8.
27. Eisner A, Thielman EJ, Falardeau J, et al. Vitreo-retinal traction and anastrozole use. Breast Cancer Res Treat; 2008.
28. Venkatesh P, Garg S. Regression of choroidal metastasis from breast carcinoma following Letrozole therapy. Clin Experiment Ophthalmol 2007;35:492-4.
29. Manquez ME, Brown MM, Shields CL, et al. Management of choroidal metastases from breast carcinomas using aromatase inhibitors. Curr Opin Ophthalmol 2006;17:251-6.
30. El-Saify WM. Choroidal metastasis in a patient with disseminated breast cancer: hormonal therapy-induced regression. Breast J 2006;12:490-2.
31. Edwards MH, Lam CS. The epidemiology of myopia in Hong Kong. Ann Acad Med Singapore 2004;33:34-8.
32. Zhang L, Gu L, Qian B, et al. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Res Treat 2009;114:327-38.
33. Cai Q, Kataoka N, Li C, et al. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2008;17:27-32.